Talecris Biotherapeutics Holdings Corp.
4101 Research Commons
79 T.W. Alexander Drive
Research Triangle Park,
NC 27709
United States - Map
Phone: 919-316-6300
Fax: 919-316-6316
Web Site: http://www.talecris.com
| Talecris Biotherapeutics Holdings Corp., a biotherapeutic and biopharmaceutical company, engages in the production and marketing of plasma-derived protein therapies worldwide. It develops, produces, markets, and distributes therapies for the people suffering from chronic and acute, immune deficiency disorders, alpha-1 antitrypsin deficiency, infectious diseases, hemophilia, and severe burns. The companys products include Gamunex, an intravenous immune globulin (IGIV) for the treatment of primary immune deficiency and autoimmune diseases; and Prolastin, an alpha-1 proteinase inhibitor (A1PI) for the treatment of alpha-1 antitrypsin deficiency-related emphysema. It also offers Hypermunes, which are antibody preparations for hepatitis, rabies, tetanus, and treatment of Rh negative women pregnant with Rh positive children; and albumin under various brand names, including Plasbumin albumin and Plasmanate plasma protein factor. Talecris Biotherapeutics Holdings Corp. is headquartered in Research Triangle Park, North Carolina. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Lawrence D. Stern , 52
Chairman and Chief Exec. Officer |
$
2.56M | N/A | Mr. John M. Hanson Jr., CPA, 56
Chief Financial Officer and Exec. VP |
$
749.00K | N/A | Mrs. Mary J. Kuhn , 50
Exec. VP of Operations |
$
583.00K | N/A | Mr. John Perkins , 38
Sr. VP and Gen. Mang. of Portfolio Management & US Bus. |
N/A
| N/A | Mr. John F Gaither Jr., 57
Exec. VP, Sec. and Gen. Counsel |
$
648.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.23% Nasdaq 
Profile
